Family Medicine · New Carlisle, IN
NPI
1568452902
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
8984 E US Highway 20
New Carlisle, IN, 46552
Phone (574) 654-8490
Groups this clinician bills Medicare through
Medicare paid, 2024
$178K
37,132 services
Medicare patients, 2024
269
Average age 73
Drug cost, 2024
$2.0M
8,709 prescriptions
Company payments, 2025
$12K
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrey P Seluzhitskiy was code J1010 (injection, methylprednisolone acetate, 1 mg), 3,320 times for 27 patients. In total Andrey P Seluzhitskiy billed 37,132 services in 110 codes, and Medicare paid $178K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-07-29.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 3,320 | 27 | $0.09 | $299 |
| 36415 Venipuncture Blood Collection | Office | 381 | 228 | $8.65 | $3,296 |
| 99214 Office E&M - Established | Office | 366 | 187 | $74.62 | $27K |
| 80053 Clinical Chemistry | Office | 355 | 225 | $10.35 | $3,674 |
| 85025 Blood Count | Office | 344 | 222 | $7.61 | $2,618 |
| 84443 Clinical Chemistry | Office | 334 | 219 | $16.46 | $5,498 |
| 83735 Clinical Chemistry | Office | 330 | 222 | $6.57 | $2,168 |
| 80061 Clinical Chemistry | Office | 312 | 217 | $13.12 | $4,093 |
| 81001 Clinical Chemistry | Office | 210 | 137 | $3.11 | $653 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 197 | 197 | $119.11 | $23K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 177 | 27 | $40.38 | $7,148 |
| 83036 Blood Count | Office | 167 | 96 | $9.52 | $1,590 |
| 99215 Office E&M - Established | Office | 162 | 102 | $109.69 | $18K |
| 96372 Injection Administration | Office | 157 | 28 | $7.92 | $1,243 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 148 | 24 | $0.72 | $107 |
By year: 2022 $143K for 24,369 services; 2023 $151K for 27,355 services; 2024 $178K for 37,132 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 381 | 228 | $8.65 | $3,296 |
| 80053 Clinical Chemistry | 355 | 225 | $10.35 | $3,674 |
| 85025 Blood Count | 344 | 222 | $7.61 | $2,618 |
| 84443 Clinical Chemistry | 334 | 219 | $16.46 | $5,498 |
| 83735 Clinical Chemistry | 330 | 222 | $6.57 | $2,168 |
| 80061 Clinical Chemistry | 312 | 217 | $13.12 | $4,093 |
| 81001 Clinical Chemistry | 210 | 137 | $3.11 | $653 |
| 83036 Blood Count | 167 | 96 | $9.52 | $1,590 |
| G0103 Prostate cancer screening; prostate specific antigen test (psa) | 102 | 102 | $18.92 | $1,930 |
| 82306 Clinical Chemistry | 82 | 58 | $29.01 | $2,379 |
Medicare prescription drug claims, 2024
In 2024, the drug Andrey P Seluzhitskiy prescribed most often to Medicare patients was Amlodipine Besylate, with 362 prescriptions and refills. In total Andrey P Seluzhitskiy wrote 8,709 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 362 | 1,078 | 118 | $1,565 |
| Atorvastatin Calcium Generic | 325 | 882 | 94 | $1,454 |
| Levothyroxine Sodium Generic | 295 | 781 | 73 | $2,033 |
| Rosuvastatin Calcium Generic | 193 | 534 | 54 | $2,442 |
| Lisinopril Generic | 176 | 521 | 60 | $554 |
| Pantoprazole Sodium Generic | 169 | 430 | 57 | $1,998 |
| Meloxicam Generic | 160 | 398 | 54 | $314 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 155 | 155 | 32 | $5,237 |
| Gabapentin Generic | 140 | 325 | 46 | $2,289 |
| Losartan Potassium Generic | 126 | 355 | 38 | $734 |
| Tramadol Hcl Generic | 123 | 127 | 32 | $638 |
| Tamsulosin Hcl Generic | 123 | 348 | 34 | $1,665 |
| Mounjaro Tirzepatide | 114 | 137 | 23 | $144K |
| Metoprolol Succinate Generic | 108 | 323 | 36 | $957 |
| Omeprazole Generic | 106 | 281 | 28 | $1,015 |
Brand drugs: 1,383 claims; generic drugs: 7,292 claims; opioid claims: 363.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrey P Seluzhitskiy $12K ($12K in general payments such as food, travel and fees) from 29 companies. The largest payer was Verity Pharmaceuticals Inc. with $7,011.
| Company | Payments | Amount |
|---|---|---|
| Verity Pharmaceuticals Inc. | 15 | $7,011 |
| Shionogi Inc 4507.T | 1 | $975 |
| ViiV Healthcare Company GSK | 23 | $597 |
| Abbvie Inc. ABBV | 23 | $474 |
| Axsome Therapeutics, Inc. AXSM | 12 | $354 |
| Amgen Inc. AMGN | 15 | $268 |
| Gilead Sciences, Inc. GILD | 13 | $266 |
| Novo Nordisk Inc NVO | 12 | $258 |
| Ardelyx, Inc. ARDX | 5 | $203 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $188 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.